디알젬

263690KOSDAQ의료용 기기 제조업

56.8 / 100

Reference Date: 2026-06-10

Financial Score22.5 / 40

News Sentiment21.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but Operating Profit is on a declining trend. Declined 11.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Dialgem is a specialized manufacturer of diagnostic X-ray systems, established in 2003, offering both analog and digital equipment along with core components. Leveraging in-house R&D and manufacturing capabilities, the company ensures high quality and competitive pricing, exporting products through 250 dealers across 120 countries globally.

Number of Employees

276people

Average Salary

57.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

7.89Industry Average 21.518.0Point

Half of industry avg (excellent)

PBR

0.60Industry Average 1.387.0Point

Half of industry avg (excellent)

ROE

7.59Industry Average 8.002.5Point

Below industry avg

Debt Ratio

12.35Industry Average 11.652.0Point

Higher than industry avg (caution)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.5% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼5.1% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 10.6% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
디알젬, 1분기 영업익 50% 증가…글로벌 DR 시장 성장 수혜
디알젬의 1분기 영업익이 50% 증가하며 글로벌 디지털 엑스레이 시장 성장에 따른 긍정적인 성과를 보고했다.
Positive
디알젬, ‘RAYMO’ 美 FDA 인증 획득…"북미 시장 공략"
디알젬의 모바일 엑스레이 시스템 RAYMO가 미국 FDA 인증을 획득하여 북미 시장 진출에 긍정적 영향을 미칠 것으로 예상됩니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 4,905Won52-week high 6,51052-week low 4,905

1-month return1.0Point

1m -11.78% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral분기보고서 (2026.03)2026-05-14